U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686094) titled 'Placental Cells for Diabetic Foot Ulcers' on June 30.

Brief Summary: The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Diabetic Foot Ulcer

Intervention: DRUG: Placenta Stem Cells

Injection of 30 M placenta stem cells into/around the diabetic foot ulcer and along the anterior and posterior tibial arteries of the index leg.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Wake Forest University Health Sciences

Disclaimer: Curated by HT Syndication....